Investing.com - Avita Medical (NASDAQ:RCEL) reported on Friday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Avita Medical announced earnings per share of $-0.6 on revenue of $3.88M. Analysts polled by Investing.com anticipated EPS of $0 on revenue of $5.17M.
Avita Medical shares are up 182.97% from the beginning of the year, still down 53.48% from its 52 week high of $55.35 set on February 19. They are outperforming the Nasdaq which is up 29.56% from the start of the year.
Avita Medical follows other major sector earnings this month
Avita Medical's report follows an earnings beat by Tencent ADR on August 12, who reported EPS of $0.49 on revenue of $16.54B, compared to forecasts EPS of $0.41 on revenue of $16.07B.
L’Oreal ADR had beat expectations on July 30 with second quarter EPS of $3.82 on revenue of $6.92B, compared to forecast for EPS of $0.85 on revenue of $6.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar